Evolus Receives Conditional FDA Acceptance of Jeuveau Brand Name

IRVINE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced the conditional acceptance from the U.S. Food and Drug Administration (“FDA”) of the Jeuveau™...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news